Author: United States. Congress. House. Committee on Government OperationsPublisher:
ISBN:
Category : AIDS (Disease)
Languages : en
Pages : 36
Book Description
Obstacles to Drug Development for HIV-related Opportunistic Infections
Author: United States. Congress. House. Committee on Government OperationsPublisher:
ISBN:
Category : AIDS (Disease)
Languages : en
Pages : 36
Book Description
Obstacles to Drug Development for HIV-related Opportunistic Infections
Author: United States. Congress. House. Committee on Government OperationsPublisher:
ISBN:
Category : AIDS (Disease)
Languages : en
Pages : 24
Book Description
Obstacles to Drug Development for HIV-related Opportunistic Infections. Seventh Report by the Committee on Government Operations Together with Separate Views. December 2, 1991. -- Ordered to be Printed
Author: United States. Congress. House. Committee on Government OperationsPublisher:
ISBN:
Category :
Languages : en
Pages : 29
Book Description
Drugs for Opportunistic Infections in Persons with HIV Disease
Author: United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations SubcommitteePublisher:
ISBN:
Category : AIDS (Disease)
Languages : en
Pages : 324
Book Description
Drugs for Opportunistic Infections in Persons with HIV Disease
Author: United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations SubcommitteePublisher:
ISBN:
Category : AIDS (Disease)
Languages : en
Pages : 346
Book Description
Roundtable for the Development of Drugs and Vaccines Against Acquired Immunodeficiency Syndrome (AIDS). Developing Effective Therapies for Aids- Related Infections
Author: Publisher:
ISBN:
Category :
Languages : en
Pages : 30
Book Description
The apparent lag in opportunistic infection (OI) drug research relative to antiretroviral research has generated substantial debate about the appropriate balance between efforts to develop antiretroviral drugs and those to develop OI therapies. The biomedical research community and pharmaceutical industry are investing heavily in the development of antiretroviral therapy for HIV Infection, and some critics have asserted that this emphasis may have slowed or diverted attention from basic and clinical research related to opportunistic infections. Other factors, however, may also be important--in particular, gaps in scientific knowledge that impede OI research and drug development. The purpose of the Roundtable's April 1991 conference was to review what is known about the epidemiology, basic biology, and treatment of the major opportunistic infections and to examine obstacles to the development of effective OI therapies. Various perspectives on these issues, including those of the biomedical and clinical research communities, the pharmaceutical industry, health care providers, and patient advocates, were presented.
The Social Impact of AIDS in the United States
Author: National Research CouncilPublisher: National Academies Press
ISBN: 0309046289
Category : Medical
Languages : en
Pages : 337
Book Description
Europe's "Black Death" contributed to the rise of nation states, mercantile economies, and even the Reformation. Will the AIDS epidemic have similar dramatic effects on the social and political landscape of the twenty-first century? This readable volume looks at the impact of AIDS since its emergence and suggests its effects in the next decade, when a million or more Americans will likely die of the disease. The Social Impact of AIDS in the United States addresses some of the most sensitive and controversial issues in the public debate over AIDS. This landmark book explores how AIDS has affected fundamental policies and practices in our major institutions, examining: How America's major religious organizations have dealt with sometimes conflicting values: the imperative of care for the sick versus traditional views of homosexuality and drug use. Hotly debated public health measures, such as HIV antibody testing and screening, tracing of sexual contacts, and quarantine. The potential risk of HIV infection to and from health care workers. How AIDS activists have brought about major change in the way new drugs are brought to the marketplace. The impact of AIDS on community-based organizations, from volunteers caring for individuals to the highly political ACT-UP organization. Coping with HIV infection in prisons. Two case studies shed light on HIV and the family relationship. One reports on some efforts to gain legal recognition for nonmarital relationships, and the other examines foster care programs for newborns with the HIV virus. A case study of New York City details how selected institutions interact to give what may be a picture of AIDS in the future. This clear and comprehensive presentation will be of interest to anyone concerned about AIDS and its impact on the country: health professionals, sociologists, psychologists, advocates for at-risk populations, and interested individuals.
Antiretroviral Drugs for All?
Author: Expanding Access to Investigational Therapies for HIV Infection and AIDS
Author: Eve K. NicholsPublisher:
ISBN:
Category : Medical
Languages : en
Pages : 88
Book Description
The call for a "parallel track" for AIDS drug developmentâ€"a proposal that would allow the early distribution of AIDS drugs to large numbers of patients in parallel with the conventional clinical trials that assess the drugs' safety and efficacyâ€"has sparked controversy within the scientific community. Questions have arisen about the risks to patients of such a plan, about its potential effect on the successful completion of standard controlled trials, and about whether the parallel track will generate useful data. Larger questions have also been raised about whether the parallel track heralds fundamental changes in the philosophy underlying drug regulation in the United States, about the costs and financing of investigational therapies and associated medical costs, and about the role of expanded access mechanisms for drugs in reaching those whose health care is generally inadequate. This volume summarizes a conference hosted by the Institute of Medicine that illuminated these issues.
Disease Control Priorities, Third Edition (Volume 6)
Author: King K. HolmesPublisher: World Bank Publications
ISBN: 1464805253
Category : Medical
Languages : en
Pages : 1027
Book Description
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.